216-55: Hypertrophic Cardiomyopathy and subcutaneous implantable cardioverter-defibrillator (S-ICD): What is the prevalence of non-eligible patients after electrocardiographic screening? | Zendy

AI Assistant Blog Pricing

216-55: Hypertrophic Cardiomyopathy and subcutaneous implantable cardioverter-defibrillator (S-ICD): What is the prevalence of non-eligible patients after electrocardiographic screening?

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.